Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (421-430 of 692) with videos related to

Pageof 70
Sort By:
Lipids|September 21, 2025
Associations Between Fatty Acid Levels in Human Blood and Trigeminovascular TissuesDaisy Zamora, Mark S Horowitz, Sharon F Majchrzak-Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancerElizabeth R Dennis, Xiaoyu Jia, Irina S Mezheritskiy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2003
Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccineSusan F Slovin, Govindaswami Ragupathi, Cristina Musselli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinomaD H Ilson, R J Motzer, R L Kradin, et al.
Cancer Detection and Prevention|November 16, 2004
Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancerGloria E Mao, Garret Morris, Qing-Yi Lu, et al.
Journal of the American Medical Informatics Association : JAMIA|March 3, 2007
Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicitiesEthan Basch, David Artz, Alexia Iasonos, et al.
Nature Reviews. Drug Discovery|September 7, 2013
Considerations for the successful co-development of targeted cancer therapies and companion diagnosticsJane Fridlyand, Richard M Simon, Jessica C Walrath, et al.
Prostate Cancer and Prostatic Diseases|October 2, 2013
Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancerO B Goodman, T W Flaig, A Molina, et al.
Cancer|March 10, 2001
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinomaE J Sherman, D G Pfister, H S Ruchlin, et al.
Pageof 70

Showing results (421-430 of 692) with videos related to

Sort By:
Pageof 70
Lipids|September 21, 2025
Associations Between Fatty Acid Levels in Human Blood and Trigeminovascular TissuesDaisy Zamora, Mark S Horowitz, Sharon F Majchrzak-Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancerElizabeth R Dennis, Xiaoyu Jia, Irina S Mezheritskiy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2003
Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccineSusan F Slovin, Govindaswami Ragupathi, Cristina Musselli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinomaD H Ilson, R J Motzer, R L Kradin, et al.
Cancer Detection and Prevention|November 16, 2004
Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancerGloria E Mao, Garret Morris, Qing-Yi Lu, et al.
Journal of the American Medical Informatics Association : JAMIA|March 3, 2007
Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicitiesEthan Basch, David Artz, Alexia Iasonos, et al.
Nature Reviews. Drug Discovery|September 7, 2013
Considerations for the successful co-development of targeted cancer therapies and companion diagnosticsJane Fridlyand, Richard M Simon, Jessica C Walrath, et al.
Prostate Cancer and Prostatic Diseases|October 2, 2013
Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancerO B Goodman, T W Flaig, A Molina, et al.
Cancer|March 10, 2001
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinomaE J Sherman, D G Pfister, H S Ruchlin, et al.
Pageof 70